Caisse des dépôts et consignations (CDC) has declared to the AMF that on October 4, through Bpifrance Investissement, acting on behalf of the Innobio fund and FPS Innovation 1, it crossed below the threshold of 25% of Advicenne's voting rights.

Following this threshold crossing, which resulted from an Advicenne capital increase, CDC stated that it indirectly held 2,664,505 shares representing 21.62% of the capital and 23.63% of the voting rights of this biopharmaceutical company.

Copyright (c) 2023 CercleFinance.com. All rights reserved.